Investigators evaluating options for gonadoreline vente en ligne require analytical precision, lot-specific certificates of analysis, and high-purity synthetic reagents. Gonadorelin, identical to endogenous gonadotropin-releasing hormone (GnRH), is a decapeptide utilized exclusively in preclinical research to examine pituitary gonadotropin regulation and reproductive neuroendocrinology. PX1 Research provides USA-manufactured, HPLC/MS-verified research peptides strictly for in vitro and laboratory experimentation.
Investigators evaluating options for gonadoreline vente en ligne require analytical precision, lot-specific certificates of analysis, and high-purity synthetic reagents. Gonadorelin, identical to endogenous gonadotropin-releasing hormone (GnRH), is a decapeptide utilized exclusively in preclinical research to examine pituitary gonadotropin regulation and reproductive neuroendocrinology. PX1 Research provides USA-manufactured, HPLC/MS-verified research peptides strictly for in vitro and laboratory experimentation.
When searching for gonadoreline vente en ligne, research institutions and laboratory investigators must navigate complex supplier metrics to ensure compound integrity and experimental reproducibility. Gonadorelin is a synthetic decapeptide corresponding exactly to native gonadotropin-releasing hormone (GnRH). In preclinical research, it serves as an essential tool for mapping the hypothalamic-pituitary-gonadal (HPG) axis, analyzing receptor kinetics, and evaluating gonadotropin secretion dynamics.
Selecting an analytical-grade supplier requires strict adherence to quality verification protocols. Substandard or unverified peptides frequently contain truncated sequence impurities, residual heavy metals, or unacceptable endotoxin burdens that compromise in vitro cell survival and skew quantitative bioassays. PX1 Research addresses these critical variables by providing fully documented, high-purity compounds cataloged in our comprehensive research library and product line, including specialized items like Gonadorelin 10mg.
Gonadorelin is a small decapeptide with the primary amino acid sequence PyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. It features an N-terminal pyroglutamic acid modification and a C-terminal glycinamide modification, both of which are critical for maintaining structural stability against exopeptidase degradation and for high-affinity binding to its target receptor.
With a molecular formula of C55H75N17O13 and a theoretical molecular weight of approximately 1182.3 g/mol, Gonadorelin exhibits clear polar characteristics that render it readily soluble in aqueous media. Preclinical literature emphasizes that maintaining the structural integrity of both the N-terminal pyroglutamyl ring and the C-terminal amide is essential when evaluating receptor-ligand interaction assays. Even minor modifications or degradation products can significantly attenuate receptor binding affinity in vitro.
In vitro data indicate that Gonadorelin functions as a full agonist at the gonadotropin-releasing hormone receptor (GnRHR), a seven-transmembrane G-protein coupled receptor (GPCR) localized on pituitary gonadotroph cells. Upon binding, the ligand-receptor complex interacts primarily with the Gq/11 protein subunit, activating membrane-bound phospholipase C (PLC).
PLC activation catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into two key intracellular second messengers: inositol 1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG). IP3 triggers rapid calcium efflux from the endoplasmic reticulum into the cytosol, while DAG activates protein kinase C (PKC). Preclinical models demonstrate that elevated intracellular calcium and PKC activity collectively stimulate exocytosis of pre-stored granules containing luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Furthermore, research indicates that the physiological response to Gonadorelin is heavily dependent on exposure pattern. Pulsatile administration promotes steady-state gonadotropin expression and release. Conversely, continuous high-concentration exposure leads to rapid receptor internalization, microaggregation, and subsequent desensitization—a phenomenon widely investigated in models of hormone-dependent pathology. Further insights into receptor signaling can be explored in our review of GnRH signaling pathways.
In laboratory settings, Gonadorelin is widely utilized to investigate neuroendocrine feedback loops and pituitary responsiveness. Rodent and non-human primate tissue models utilize Gonadorelin to measure acute LH and FSH secretory spikes using enzyme-linked immunosorbent assays (ELISA) or radioimmunoassays (RIA).
Cellular models utilizing immortalized gonadotroph cell lines (such as LβT2 or αT3-1 cells) employ Gonadorelin to explore transcriptomic changes in gonadotropin subunit genes (Lhb, Fshb, and Gnrhr). Researchers also leverage this decapeptide to map intracellular crosstalk between the MAPK/ERK pathway and calcium signaling networks, shedding light on how neurohormonal frequency decoding occurs at the cellular level.
In addition to baseline physiological studies, researchers examining target compounds across our complete catalog of all peptides utilize Gonadorelin as a positive control standard for evaluating novel GnRHR superagonists, partial agonists, and non-peptide antagonists.
To contextualize the scientific utility of Gonadorelin, it is essential to compare its pharmacological properties with modified peptide analogues designed for prolonged half-life or enhanced potency. Native Gonadorelin exhibits a rapid clearance rate and short terminal half-life in physiological matrices (typically 2 to 10 minutes in animal models) due to rapid cleavage by endopeptidases at the Gly6-Leu7 bond.
In contrast, synthetic analogues incorporate structural modifications—such as D-amino acid substitutions at position 6 or ethylamide modifications at the C-terminus—to resist enzymatic cleavage. When designing comparative studies, investigators frequently compare Gonadorelin alongside Triptorelin, Leuprolide, and Buserelin. While modified analogues induce rapid receptor downregulation due to sustained occupancy, Gonadorelin remains the gold standard for modeling short-duration, physiological pulsatile signaling.
When ordering via gonadoreline vente en ligne channels, verification of chemical identity and purity is paramount. PX1 Research mandates that every production lot undergoes rigorous analytical testing in an ISO 17025 accredited laboratory prior to release.
Purity is quantitatively determined using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The resulting chromatogram must demonstrate a sharp, symmetrical peak corresponding to the target decapeptide, with an integrated peak area exceeding 98.0%. Truncated sequences, insertion peptides, and residual synthesis side-products are identified and quantified via UV detection at 214 nm.
Identity verification is performed using Electrospray Ionization Mass Spectrometry (ESI-MS). The spectrum must confirm the theoretical monoisotopic mass of 1182.3 Da (typically observed as [M+H]+ and [M+2H]2+ mass-to-charge ratios), verifying that the exact amino acid sequence was successfully synthesized without unexpected side-chain modifications. Every lot is delivered with a complete, downloadable Certificate of Analysis (COA).
For researchers conducting primary cell culture, pituitary slice incubations, or sensitive microfluidic assays, bacterial endotoxin contamination poses a critical threat to experimental validity. Lipopolysaccharides (LPS) present in unrefined peptide preparations can trigger inflammatory signaling cascades (e.g., NF-κB activation) that obscure specific GnRHR-mediated responses.
PX1 Research subjects every batch of Gonadorelin to quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing. We enforce strict internal release limits, guaranteeing endotoxin levels under 0.01 EU/mg. This rigorous quality control step eliminates baseline cellular toxicity caused by bacterial debris, ensuring highly reproducible experimental data across experimental replicates.
Proper handling and reconstitution protocols are vital to prevent peptide aggregation, physical degradation, or loss of biological activity in vitro. Lyophilized Gonadorelin should be allowed to equilibrate to room temperature inside a desiccator cabinet before opening the vial to prevent atmospheric moisture condensation.
For standard cellular assays, reconstitution should be performed using sterile, deionized, post-purification laboratory water (0.22 µm filtered) or sterile physiological buffers such as phosphate-buffered saline (PBS, pH 7.4). If long-term stock storage is required, incorporating 0.9% benzyl alcohol or using bacteriostatic water can inhibit microbial proliferation.
Researchers should avoid high-shear mechanical agitation during dissolution. Gentle vortexing or manual inversion is recommended. Once dissolved, stock solutions should be aliquoted into single-use polypropylene microtubes to eliminate repeated freeze-thaw cycles, which can cause peptide cleavage and aggregation.
In its lyophilized state, high-purity Gonadorelin demonstrates excellent long-term chemical stability when stored under controlled environment conditions. The peptide powder should be maintained at -20°C for short-to-medium duration storage (up to 12 months) or at -80°C for extended research timelines.
Desiccant packs should be kept in storage containers to shield the powder from ambient humidity. Once reconstituted into working stock solutions, aliquots stored at 4°C are stable for short durations (typically 1 to 7 days, depending on buffer pH and microbial controls). Working solutions stored at -20°C maintain target stability for up to 30 days, provided temperature fluctuations are minimized.
PX1 Research maintains a streamlined supply chain tailored to academic laboratories, biotechnology institutions, and contract research organizations (CROs). All peptides are synthesized in state-of-the-art GMP-compliant facilities within the USA and dispatched directly from centralized distribution hubs in California and Arizona.
Orders placed before cut-off times Monday through Friday qualify for same-day dispatch, reducing transit delays and ensuring compound integrity. Institutional buyers requiring larger quantities or continuous supply arrangements can establish dedicated procurement terms through our specialized /wholesale portal.
What is the primary specification for Gonadorelin sourced from PX1 Research?
PX1 Research provides Gonadorelin certified at ≥98.0% purity as determined by RP-HPLC, with sequence identity confirmed via ESI-MS. All lots undergo LAL assay testing to verify endotoxin levels below 0.01 EU/mg.
Can Gonadorelin purchased here be used in human clinical applications?
No. All products offered by PX1 Research, including Gonadorelin, are strictly designed for in vitro, laboratory, and preclinical research use only. They are not intended for human consumption, therapeutic, diagnostic, or clinical use.
What analytical documentation accompanies a shipment of Gonadorelin?
Every lot is accompanied by a downloadable, lot-specific Certificate of Analysis (COA) containing RP-HPLC chromatograms, Mass Spectrometry (ESI-MS) spectra, purity integration data, and quantitative endotoxin test results.
How does native Gonadorelin differ from long-acting GnRH agonists like Triptorelin?
Gonadorelin possesses the exact amino acid sequence of native GnRH and exhibits a short enzymatic half-life. Modified agonists like Triptorelin incorporate D-amino acids at position 6 to resist cleavage, resulting in prolonged receptor occupancy and sustained pituitary downregulation.
What solvent is recommended for reconstituting Gonadorelin in cell culture assays?
Reconstitution is typically carried out using sterile 0.22 µm filtered laboratory water or sterile phosphate-buffered saline (PBS, pH 7.4). For stock solutions requiring extended storage at 4°C, bacteriostatic water containing 0.9% benzyl alcohol may be utilized.
How should lyophilized Gonadorelin powder be stored upon receipt?
Lyophilized Gonadorelin should be stored at -20°C for short-to-medium storage or -80°C for long-term preservation. Protect the vial from moisture exposure by allowing it to reach room temperature before opening.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and shipped directly from distribution locations in California and Arizona, with same-day shipping available for orders placed Monday through Friday.
What options are available for institutional bulk ordering of research peptides?
Academic institutions, CROs, and industrial labs requiring high-volume supplies can apply for institutional accounts and bulk pricing through our wholesale portal at /wholesale.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.